Chest pain urgent care encounters require a deliberately risk-averse approach. Most patients will not have acute coronary syndrome (ACS), but the consequences of missing ACS, pulmonary embolism (PE), acute aortic syndrome, pneumothorax, esophageal rupture, myocarditis, or other time-sensitive disease are substantial. Urgent care clinicians should prioritize rapid identification of instability and conditions that require emergency department (ED) evaluation rather than attempting to definitively diagnose every cause of chest discomfort in the ambulatory setting.

This guide addresses evaluation of undifferentiated acute or subacute chest pain in urgent care. It is not a substitute for local transfer protocols, emergency medical services (EMS) medical direction, institutional ECG and troponin pathways, or current specialty guidelines.

Clinical overview and significance

“Chest pain” includes pressure, tightness, heaviness, burning, discomfort, or pain located in the chest, shoulders, arms, neck, jaw, back, epigastrium, or upper abdomen. Dyspnea, diaphoresis, nausea, fatigue, presyncope, syncope, and unexplained weakness may be anginal equivalents, particularly in older adults, women, and patients with diabetes or chronic kidney disease.[1]

The urgent care objective is not simply to identify musculoskeletal or gastrointestinal causes. It is to determine whether a potentially life-threatening cardiopulmonary, vascular, or thoracic process is reasonably possible and whether the clinic has the diagnostic capability, monitoring, staff, and transfer resources necessary to safely manage the patient. A normal appearance, a reassuring single ECG, pain reproducible with palpation, or symptom improvement after an antacid does not independently exclude ACS or other emergencies.

Immediate triage and stabilization

Use a front-end process that obtains vital signs promptly and brings concerning patients to a monitored area without delay. Assess airway, breathing, circulation, mental status, and perfusion. Obtain a focused initial history while arranging a 12-lead ECG; do not delay ECG acquisition for a detailed history or registration process.

Activate EMS or arrange emergency transfer immediately for any of the following

• Hemodynamic instability, shock, altered mental status, cyanosis, severe respiratory distress, persistent hypoxemia, or syncope with ongoing symptoms.
• Ongoing ischemic-sounding chest discomfort, especially with diaphoresis, dyspnea, nausea, pallor, or radiation to the arm, jaw, back, or epigastrium.
• New ischemic ECG findings, including ST-segment elevation, dynamic ST-segment depression, concerning T-wave changes in the appropriate clinical context, or a new/presumed new left bundle-branch block with symptoms concerning for occlusion MI.
• Ventricular tachycardia, unstable bradyarrhythmia, high-grade atrioventricular block, rapid arrhythmia with ischemic symptoms, or any rhythm associated with instability.
• Concern for acute aortic syndrome, PE, tension pneumothorax, pericardial tamponade, esophageal rupture, severe pneumonia/sepsis, acute heart failure, or another emergent diagnosis.
• Persistent symptoms despite initial supportive care, recurrent symptoms during observation, or inability to establish a safe low-risk disposition.

Patients requiring ED evaluation should generally be transported by EMS rather than private vehicle. EMS enables monitoring, repeat ECGs, treatment escalation, and rapid response to deterioration. Maintain observation, obtain serial vital signs, and reassess symptoms while awaiting transfer. Do not allow a patient with suspected ACS or another unstable condition to drive.

Focused history

Use a structured but efficient history. The quality of the history matters more than whether a symptom is described as “typical” or “atypical”; current guidance discourages dismissive labeling because ischemic presentations vary substantially.[1]

Characterize the symptom

• Onset: abrupt versus gradual; symptoms maximal at onset raise concern for acute aortic syndrome, pneumothorax, PE, or rupture.
• Provocation: exertion, emotional stress, cold exposure, meals, swallowing, position, inspiration, cough, movement, or palpation.
• Quality and location: pressure/heaviness, sharp pain, burning, tearing, pleuritic pain, focal tenderness, retrosternal or epigastric discomfort.
• Radiation: arm, shoulder, jaw, neck, interscapular back, abdomen, or flank.
• Timing: duration, progression, frequency, pain at rest, nocturnal symptoms, and whether symptoms are new, accelerating, or different from established angina.
• Associated symptoms: dyspnea, diaphoresis, nausea/vomiting, palpitations, presyncope/syncope, fever, cough, hemoptysis, unilateral leg symptoms, neurologic deficits, or dysphagia.

Assess risk and context

• Known coronary artery disease, prior myocardial infarction, coronary intervention, heart failure, valvular disease, arrhythmia, cardiomyopathy, or aortic aneurysm/dissection.
• Hypertension, diabetes, dyslipidemia, smoking/nicotine use, stimulant use, obesity, chronic kidney disease, inflammatory disease, and family history of premature coronary disease or sudden death.
• PE risks: prior venous thromboembolism, active cancer, recent surgery/trauma, immobilization, long travel, estrogen exposure, pregnancy/postpartum status, thrombophilia, and unilateral leg swelling or pain.
• Aortic risks: known aneurysm, bicuspid aortic valve, Marfan syndrome or another heritable aortopathy, recent aortic manipulation, severe hypertension, cocaine/amphetamine exposure, and family history of dissection or sudden unexplained death.
• Recent viral illness, fever, vaccination timing when clinically relevant, or new exercise intolerance that may suggest myocarditis or pericarditis.
• Medication review: antiplatelets, anticoagulants, beta-blockers, rate-limiting calcium-channel blockers, phosphodiesterase-5 inhibitors, stimulants, cocaine/amphetamines, insulin or sulfonylureas, and medications that may cause pill esophagitis. Clarify allergies, bleeding history, and prior contrast reactions.

Focused examination

Repeat vital signs rather than relying on one triage set. Include temperature, heart rate, respiratory rate, blood pressure, oxygen saturation, pain score, and mental status. Consider blood pressure in both arms when acute aortic syndrome is a meaningful possibility, recognizing that a normal inter-arm comparison does not exclude dissection.[5]

The examination should include general appearance; skin perfusion and diaphoresis; cardiac rate/rhythm and murmurs; lung sounds and work of breathing; chest-wall tenderness; abdomen and epigastrium; peripheral pulses; lower-extremity edema/asymmetry; and a focused neurologic assessment when indicated. Look for signs of heart failure, including jugular venous distention, pulmonary crackles, new edema, or an S3. A new diastolic murmur, pulse deficit, focal neurologic deficit, or limb ischemia increases concern for acute aortic syndrome.

Reproducible pain with chest-wall palpation supports a musculoskeletal source but should be interpreted cautiously. Patients may have musculoskeletal tenderness and ACS simultaneously, particularly after exertion, coughing, falls, or prolonged positioning.

Differential diagnosis

Must-not-miss diagnoses

• ACS, including ST-elevation myocardial infarction, non-ST-elevation myocardial infarction, and unstable angina.
• Acute aortic syndrome: dissection, intramural hematoma, or penetrating aortic ulcer.
• PE.
• Tension pneumothorax, spontaneous pneumothorax, severe pneumonia, or acute severe asthma/chronic obstructive pulmonary disease exacerbation.
• Pericarditis with tamponade physiology; myocarditis.
• Acute decompensated heart failure and malignant arrhythmia.
• Esophageal rupture, upper gastrointestinal bleeding with demand ischemia, or severe pancreatobiliary disease when clinically plausible.

Common nonemergent diagnoses after appropriate exclusion of dangerous causes

• Chest-wall strain, costochondritis, rib injury, cervical/thoracic radiculopathy, or myofascial pain.
• Gastroesophageal reflux disease, esophagitis, dyspepsia, or esophageal spasm.
• Viral respiratory illness, bronchitis, pleurisy, or uncomplicated pneumonia.
• Panic symptoms or anxiety. This should remain a diagnosis of exclusion when symptoms are new, severe, exertional, or accompanied by concerning physiologic findings.

Diagnostic approach in urgent care

Electrocardiography

Obtain a 12-lead ECG promptly for acute chest pain, chest pressure, exertional dyspnea, suspected anginal equivalents, syncope with possible cardiac cause, or concerning palpitations. Compare with prior ECGs whenever available. A normal ECG does not exclude ACS, particularly early after symptom onset or with intermittent ischemia. Repeat ECGs are appropriate when symptoms persist, recur, evolve, or clinical suspicion remains high.[1,2]

ECG findings that should prompt emergency transfer include ST-segment elevation or depression, dynamic changes, posterior infarction patterns, ischemic T-wave abnormalities in an appropriate syndrome, new significant conduction abnormalities, or dangerous dysrhythmias. If the machine interpretation and clinician interpretation differ, prioritize expert over-read and the clinical picture; automated ECG interpretation is not sufficiently reliable to rule out ischemia.

Troponin testing

High-sensitivity cardiac troponin (hs-cTn) is the preferred biomarker for myocardial injury, but safe interpretation requires an assay-specific, validated clinical decision pathway with defined timing, delta criteria, quality controls, and reliable follow-up capability.[1,2] A single negative troponin should not be used to rule out MI in patients with concerning symptoms, early presentation, an abnormal ECG, or elevated baseline risk unless the patient meets all criteria of the specific validated pathway used by the institution.

Urgent care settings should not create ad hoc “rule-out” protocols using non-high-sensitivity troponin, unvalidated point-of-care troponin assays, or isolated reference-range values. Troponin elevation indicates myocardial injury, not necessarily type 1 MI; renal dysfunction, heart failure, tachyarrhythmia, PE, myocarditis, sepsis, and other conditions may elevate troponin. Any unexplained acute elevation or clinically significant delta generally warrants ED assessment.

Chest radiography and point-of-care ultrasound

Chest radiography may identify pneumothorax, infiltrate, edema, pleural effusion, fracture, or mediastinal abnormalities, but a normal film does not exclude PE, ACS, or acute aortic syndrome. Chest radiography should not delay EMS transfer when a life-threatening diagnosis is suspected.

Point-of-care ultrasound can support recognition of pleural sliding absence, B-lines, pericardial effusion, gross left-ventricular dysfunction, right-heart strain, or proximal deep venous thrombosis when performed by clinicians with training and quality assurance. However, it is operator-dependent and should not be used as a stand-alone test to exclude PE, tamponade, ACS, or aortic dissection. A concerning ultrasound finding should accelerate transfer; a nondiagnostic or normal study should not reassure clinicians away from transfer when pretest probability is meaningful.

D-dimer and PE assessment

Use a validated pretest-probability assessment before ordering D-dimer testing. D-dimer is most useful in patients with low or, depending on the assay and pathway, intermediate probability of PE. It should not be used to rule out PE in a patient with high clinical probability, instability, or a presentation that warrants immediate imaging and ED treatment. D-dimer values rise with age, pregnancy, cancer, inflammation, infection, hospitalization, and many other conditions; a positive result is nonspecific.[4]

Age-adjusted D-dimer thresholds may be used only with the validated assay and institutional protocol. Point-of-care D-dimer assays may have lower sensitivity than central laboratory testing and should be restricted to carefully selected low-risk patients if used at all.[4] Most urgent care settings should transfer patients with suspected PE who cannot be confidently excluded using a validated pathway available at that site.

Red flags by diagnosis

ACS

• Pressure, heaviness, squeezing, or discomfort with exertion or at rest; new or worsening symptoms; associated diaphoresis, nausea, dyspnea, or syncope.
• Known coronary disease, diabetes, chronic kidney disease, older age, or multiple atherosclerotic risk factors.
• Abnormal or evolving ECG, hypotension, heart failure signs, or arrhythmia.

Acute aortic syndrome

• Abrupt severe chest, back, abdominal, or migratory pain, often maximal at onset.
• Neurologic symptoms, syncope, pulse deficit, limb ischemia, new aortic regurgitation murmur, shock, or a known aortic aneurysm/heritable aortopathy.
• Do not rely on “tearing” pain as a required descriptor. The condition may present with sharp or stabbing pain, dyspnea, neurologic deficits, or painless malperfusion.[5]

PE

• Pleuritic chest pain, unexplained dyspnea, tachycardia, hypoxemia, syncope, hemoptysis, unilateral leg swelling, or VTE risk factors.
• Pregnancy or the postpartum period, active cancer, estrogen exposure, recent surgery, trauma, or immobilization.

Pneumothorax, tamponade, and esophageal rupture

• Sudden unilateral pleuritic pain with dyspnea or asymmetric breath sounds.
• Hypotension, distended neck veins, muffled heart sounds, or rapidly worsening dyspnea suggesting tamponade physiology.
• Severe chest pain after forceful vomiting, retching, or esophageal instrumentation, particularly with fever, subcutaneous emphysema, or systemic toxicity.

Management while arranging emergency transfer

Place the patient at rest, establish appropriate monitoring, obtain serial vital signs, repeat ECGs for recurrent or persistent ischemic symptoms, and follow local emergency response procedures. Provide supplemental oxygen only when clinically indicated, such as hypoxemia, respiratory distress, or shock; routine oxygen for normoxemic suspected ACS is not beneficial.

If ACS is suspected and there is no aspirin allergy, active significant bleeding, known bleeding disorder, or strong concern for acute aortic syndrome, a common adult prehospital/acute-care approach is chewable aspirin 162 to 325 mg by mouth once while transfer is being arranged.[3] Confirm whether the patient has already taken aspirin and follow local protocol. Aspirin is not a benign default treatment: avoid or obtain emergency medical direction when there is suspected aortic dissection, active gastrointestinal bleeding, severe aspirin hypersensitivity, or another major contraindication. Pediatric use for undifferentiated chest pain is not routine and should be directed by pediatric emergency or cardiology consultation.

Patients with a prescribed nitroglycerin supply may take it only according to their established plan and local protocol. Nitroglycerin should not be used as a diagnostic test for ACS. Avoid it in hypotension, suspected right-ventricular infarction or preload-dependent states, suspected severe aortic stenosis when clinically relevant, and recent phosphodiesterase-5 inhibitor use because severe hypotension can occur. For commercially available sublingual nitroglycerin tablets, labeled adult use commonly permits one 0.3 mg, 0.4 mg, or 0.6 mg tablet sublingually every 5 minutes as needed, with no more than three tablets in 15 minutes; urgent care clinicians should independently verify the exact product labeling, contraindications, and local EMS/medical-direction protocol before use.[7]

Do not initiate empiric anticoagulation, fibrinolysis, dual antiplatelet therapy, beta-blockade, or intravenous antihypertensive treatment for undifferentiated chest pain in routine urgent care unless the clinic has explicit protocols, appropriate monitoring, immediate physician support, and transfer coordination. These treatments can be harmful in aortic dissection, bleeding, bradycardia, acute heart failure, or other alternative diagnoses.

Special populations

Pregnancy and postpartum patients

Pregnancy does not protect against ACS, PE, aortic dissection, cardiomyopathy, or spontaneous coronary artery dissection. Consider PE, hypertensive disorders, peripartum cardiomyopathy, and aortic disease early in pregnant or postpartum patients with chest pain, dyspnea, syncope, or leg symptoms. D-dimer interpretation and imaging selection require pregnancy-specific pathways; do not apply standard nonpregnant algorithms uncritically. Urgent ED or obstetric-capable evaluation is appropriate when a serious diagnosis is possible.

Pediatric and adolescent patients

Ischemic coronary disease is uncommon in children, but myocarditis, pericarditis, congenital coronary anomalies, hypertrophic cardiomyopathy, dysrhythmia, pneumothorax, pneumonia, asthma, trauma, sickle-cell complications, and stimulant-associated events may present with chest pain. Exertional pain, exertional syncope, palpitations, abnormal cardiac examination, abnormal ECG, fever with tachycardia out of proportion, known heart disease, or a family history of sudden death warrants ED transfer or urgent pediatric specialty input. Medication doses in children must be weight-based with maximum-dose limits independently verified.

Older adults and patients with renal or hepatic impairment

Older adults may present with dyspnea, weakness, syncope, confusion, nausea, or fatigue rather than prominent pain. Chronic kidney disease increases baseline cardiovascular risk and complicates troponin interpretation because chronic myocardial injury may be present; serial values and clinical context are essential. Renal dysfunction also affects contrast imaging decisions and dosing of many anticoagulants, analgesics, and other medications. Hepatic impairment, thrombocytopenia, anticoagulant use, and alcohol-related disease increase bleeding risk. These factors should lower the threshold for ED evaluation rather than encourage abbreviated outpatient testing.

Disposition and follow-up

Emergency transfer

Transfer any patient with instability, concerning symptoms, abnormal ECG, elevated or indeterminate troponin, suspected PE/aortic syndrome/pneumothorax/tamponade, inability to complete a validated diagnostic pathway, or unreliable follow-up. Intermediate-risk patients identified through validated ED pathways often need observation, serial hs-cTn testing, and selective noninvasive cardiac testing that exceed usual urgent care capabilities.[2]

Outpatient management may be reasonable only when all of the following are true

• A dangerous diagnosis is clinically unlikely after an appropriate history, examination, and available testing.
• Symptoms are consistent with a nonemergent condition, are improving or stable, and there are no red flags.
• ECG is reassuring when indicated, and any troponin strategy used conforms to a validated assay-specific protocol.
• The patient has stable vital signs, intact decision-making capacity, safe transportation, and reliable access to follow-up.
• The clinician documents why outpatient care is reasonable and gives explicit return precautions.

For clearly musculoskeletal pain, conservative nonpharmacologic care may include activity modification, local heat or ice, and follow-up. Analgesic selection should be individualized. Nonsteroidal anti-inflammatory drugs can worsen renal function, fluid retention, blood pressure, gastrointestinal bleeding risk, and anticoagulant-related bleeding; they should be avoided or used cautiously in patients with renal disease, heart failure, peptic ulcer disease, anticoagulant therapy, pregnancy considerations, or suspected ischemic disease. Verify dosing, interactions, pregnancy status, renal/hepatic function, and current labeling before prescribing any medication.

Return and emergency precautions

Patients discharged from urgent care with a presumed nonemergent cause should be instructed to seek emergency care immediately for recurrent, worsening, persistent, or exertional chest discomfort; dyspnea; syncope; palpitations with dizziness; diaphoresis; vomiting; hemoptysis; new neurologic symptoms; fever with clinical worsening; unilateral leg swelling; or any new concern. Arrange follow-up based on the working diagnosis and risk profile, often within several days for unresolved symptoms or cardiovascular risk assessment.

Documentation considerations

• Time of symptom onset; symptom trajectory; relevant risk factors; associated symptoms; and pertinent negatives.
• Initial and serial vital signs, appearance, focused examination findings, and reassessments.
• ECG acquisition time, clinician interpretation, comparison with prior ECG when available, and reason for repeat ECGs or transfer.
• Troponin assay type, collection times, result interpretation according to the institutional pathway, and limitations of testing if applicable.
• Pretest-probability reasoning for PE or acute aortic syndrome and why testing, transfer, or outpatient care was selected.
• Medications administered or withheld, including contraindication screening and response.
• Transfer method, receiving facility, clinician-to-clinician handoff, EMS activation time, and patient status at departure.
• For discharge: diagnostic uncertainty, shared decision-making when applicable, follow-up plan, and specific written emergency precautions.

Clinical takeaways

• In urgent care, chest pain evaluation is primarily a triage and risk-stratification task. Identify life-threatening disease early and transfer when the setting cannot safely complete evaluation.
• Obtain and interpret an ECG promptly; repeat it when symptoms or concern persist. A single normal ECG does not rule out ACS.
• Use hs-cTn only within a validated, assay-specific clinical decision pathway. Do not improvise a rule-out strategy with isolated testing.
• Apply PE and aortic-dissection risk assessment before relying on D-dimer, chest radiography, symptom descriptors, or a reassuring examination.
• Older adults, pregnant/postpartum patients, patients with chronic kidney disease, and patients with known cardiovascular disease may have atypical presentations and deserve a lower threshold for ED transfer.
• When uncertainty remains, the safer disposition for potentially serious chest pain is monitored EMS transfer, not outpatient reassurance.

References

1. Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;144(22):e368-e454. doi:10.1161/CIR.0000000000001029.
2. Kontos MC, de Lemos JA, Deitelzweig SB, Diercks DB, Gore MO, Hess EP, et al. 2022 ACC expert consensus decision pathway on the evaluation and disposition of acute chest pain in the emergency department: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2022;80(20):1920-1930. doi:10.1016/j.jacc.2022.08.750.
3. Rao SV, O’Donoghue ML, Ruel M, Rab T, Tamis-Holland JE, Alexander JH, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2025;85(22):2135-2237. doi:10.1016/j.jacc.2024.11.009.
4. Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society. Eur Heart J. 2020;41(4):543-603. doi:10.1093/eurheartj/ehz405.
5. Isselbacher EM, Preventza O, Hamilton Black J 3rd, Augoustides JGT, Beck AW, Bolen MA, et al. 2022 ACC/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2022;146(24):e334-e482. doi:10.1161/CIR.0000000000001106.
6. Tomaszewski CA, Nestler D, Shah KH, Sudhir A, Brown MD, Shih RD, et al. Clinical policy: critical issues in the evaluation and management of emergency department patients with suspected non-ST-elevation acute coronary syndromes. Ann Emerg Med. 2018;72(5):e65-e106. doi:10.1016/j.annemergmed.2018.07.045.
7. National Library of Medicine. Nitroglycerin sublingual tablet: prescribing information. DailyMed [Internet]. Bethesda (MD): National Library of Medicine; cited 2026 Aug 15.

Educational disclaimer: This article is intended for clinician education and does not replace patient-specific clinical judgment, emergency consultation, local protocols, product labeling, or current guidelines. Medication dosing, contraindications, interactions, pregnancy considerations, and renal/hepatic adjustments must be independently verified before clinical use.